Best CAR T-cell therapy hematologist-oncologists: TOP 25 doctors

Dr. K.K. Iswaran is a highly experienced Obstetrician and Gynaecologist with 25+ years of experience in Obstetrics & Gynaecology Reproduction Medicine, IUI - Intrauterine Insemination, Ovulation Induction Procedure, Ovarian Drilling (Multiperforation), Urethral Valves, and more. He holds a Fellowship, Diploma, and MBBS from the Ronald O Perelman and Claudia Cohen Centre, Ireland, and the University of Mysore, India respectively.

Dr. Ronit El Hasid is the Head of Pediatric Oncohematology and Oncology at Dana Dwek Children’s Hospital (Sourasky). She specializes in bone marrow and umbilical blood transplantation and has conducted over 300 transplantations and published 50 papers and 40 reports. She is a member of American Association for Hematology and Israeli Society for Pediatric Hematooncology, and has previously practiced in the City of Hope Hospital (Los-Angeles) and other medical centers in Israel.

Professor Fabio Ciceri is the Head of the Hematology and Bone Marrow Transplantation Unit at San Raffaele Research Hospital and the Blood Transfusion Centre. He has over 180 papers published and has held various Medical and Teaching positions since 1989. He is a member of multiple organizations related to Hematology and was awarded a Merit Recognition Award at the University of Ferrara. He is a Principal Investigator in Cell and Gene Therapy clinical trials for haematological cancers, immune-deficiencies, and neuromuscular disorder.

• Dr. Susana Rives Sola specializes in advanced CAR T-cell therapies for children.
• She utilizes methods such as leukapheresis, cell engineering, and lymphodepletion.
• Incorporates innovative techniques: CTL019, axicabtagene ciloleucel, and tisagenlecleucel.
• International practice includes Spain, the United States, and other European countries.
• Holds certifications in Pediatric Hematology and Hematopoietic Transplantation.
• Member of the European Society for Blood and Marrow Transplantation (EBMT).
• Offers online consultations for international patients seeking CAR T-cell therapy expertise.
• Fluent in Spanish and English, facilitating communication with a broad patient base.

Dr. Dror Levin is a senior pediatrician and director of the blood disorder and bone cancer (sarcoma) treatment departments at Children's Hospital "Dana" and Medical Center "Sourasky" respectively. He is a specialist in pediatric medicine, hematology, and oncology, with additional experience studying abroad at the Rizzoli Orthopaedic Institute in Italy.

• Dr. López-Ibor specializes in CAR T-cell therapy, an innovative cancer treatment.
• Utilizes methods like leukapheresis, cell transduction, and in vitro cell expansion.
• International practice includes the United States, where she trained in Oncology.
• Directs Pediatric Hematology/Oncology Unit, with expertise in leukemia treatment.
• Holds a Medicine degree from Complutense University and a Doctorate from the University of Barcelona.
• Professional memberships in pediatric cancer societies, contributing to her specialization.
• Conducts online consultations, facilitating access for international patients.
• Fluent in English and Spanish, ensuring clear communication with diverse patients.

• Dr. Serdar Bedii Omay specializes in advanced CAR T-cell therapy.
• Innovative CAR T-cell methods include leukapheresis, cell engineering, and infusion.
• Trained internationally, including Molecular Hematology in Japan.
• Holds certification in Internal Medicine and Hematology.
• Member of prestigious hematology societies, expert in bone marrow transplantation.
• Offers remote consultations for patients seeking CAR T-cell therapy.
• Speaks Turkish and English, facilitating international patient communication.

• Dr. Birol Baytan specializes in innovative CAR T-cell therapy for childhood cancers.
• Performs CAR T-cell therapy using techniques like leukapheresis, cell engineering, and infusion.
• International practice in Turkey, a leader in pediatric bone marrow transplantation.
• Holds certifications in Pediatric Hematology and Oncology.
• Member of prestigious medical associations in hematology and pediatric cancer.
• Offers online consultations for CAR T-cell therapy, enhancing patient access.
• Fluent in Turkish and English, ensuring clear communication with diverse patients.

Dr. Girish V. Badarkhe is an experienced hematology-oncologist at HCG Manavata Cancer Centre, Nashik, with MBBS, MD, and DM degrees. He has 13+ years of expertise in leukemia, multiple myeloma, and bone marrow transplant, and has received awards for his professional and hard work.

• Dr. Songul Serefhanoglu specializes in CAR T-cell therapy at ISU Medical Park.
• Expert in hematopoietic stem cell transplantation, applicable in CAR T-cell methods.
• Utilizes innovative techniques: gene editing, signaling pathway modulation, and safety switch designs.
• International training from Hacettepe University, renowned for medical advancements in Turkey.
• Professor status with extensive research and clinical experience in hematology.
• Holds significant professional memberships, indicating advanced practice and knowledge.
• Conducts online consultations for patients seeking CAR T-cell therapy expertise.

Prof. Dr. Osman İLHAN graduated from Ankara University Faculty of Medicine in 1978. After completing his internal medicine residency at the same faculty in 1982, he served as a senior resident at the GATA Hematology Clinic during his military service. After completing his mandatory service at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for a subspecialty. In 1990, he became an associate professor of hematology. He worked in Genoa, Italy to increase his knowledge and experience in leukemia. He was part of the team that performed the first bone marrow stem cell transplant in Turkey. In 1996, he went to the MD Anderson Cancer Center in the USA to work on "Stem Cell Mobilization, Cryopreservation, and Transplantation." In 1996, he became a professor of hematology. In 1999, he was elected as the regional president of ESFH (European Society for Hemapheresis). Dr. İlhan, who was the founder and president of the Hemapheresis Society in 2000, joined the World Apheresis Association (WAA) in 2001. He became the President of the Turkish Hematology Association in October 2001. Dr. İlhan, who is an active member of the European Hematology Association (EHA), was a member of the accreditation committee (ECAH) for education. He played a role in the accreditation of Turkish hematologists in CME credits by participating in the accreditation of congresses and courses held in Turkey as a Provider Status. He served as the founding president of the Cellular Therapy and Regenerative Medicine Association established in 2008. He became the founding president of the Geriatric Hematology Association in 2011. He is the Honorary President of the World Apheresis Congress (WAA) held in 2012. Dr. İlhan, who previously served on drug licensing and ethics committees at the Ministry of Health, has also served as the Chairman of the Photopheresis-Apheresis Commission and the Scientific Committee for Bone Marrow Transplantation, as well as the Chairman of the National Organ Tissue Cell Coordination Board, the Scientific Board of Cord Blood, and the Stem Cell Research Board. He is the founding president of the STEM CELL FOUNDATION and has played an important role in the establishment of TURKOK (Turkish Stem Cell Donor Bank). Dr. İlhan has over 300 publications in journals registered in PubMed and more than 5000 citations. He holds the Platinum CME certificate from the European Hematology Association. He owns four brands/patents named “Kökten Çözüm (Deep Solution), Telehematoloji (Telehematology), Hemaferez (Hemapheresis), Kanser Kök Hücresi (Cancer Stem Cell)”. He is currently the President of the Ankara Medical Association. Prof. Dr. Osman İlhan, who served at Ankara University Faculty of Medicine for 50 years, began working at Özel Koru Ankara Hospital as of January 1, 2023.

His medical interests include:

Hematopoietic Stem Cell Transplantation (Autologous, Allogeneic)

Acute Leukemia

Chronic Leukemia Treatments

Hodgkin Lymphoma

Non-Hodgkin Lymphoma Treatments

Multiple Myeloma Treatments, MDS

Aplastic Anemia

ITP

TTP Treatments

Hypercoagulability

Hereditary Thrombophilia Treatments

Therapeutic Apheresis

Photopheresis

Geriatric Hematology Diseases.